| Mar 4 |
Tech Stocks Take A Beating: This Is How To Make Tricky Trading Decisions In Tough Markets
|
| Feb 16 |
Organogenesis Appoints David C. Francisco as Chief Financial Officer
|
| Feb 11 |
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
|
| Feb 9 |
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February and March
|
| Feb 9 |
The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement
|
| Feb 8 |
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 16, 2021
|
| Feb 4 |
Organogenesis Holdings' (ORGO) Shares March Higher, Can It Continue?
|
| Jan 21 |
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
|
| Jan 20 |
Earnings Estimates Rising for ORGANOGENESIS (ORGO): Will It Gain?
|
| Jan 15 |
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
|
| Jan 14 |
Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3%
|
| Jan 14 |
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
|
| Jan 14 |
Enrollment underway in Organogenesis' late-stage study with amniotic allograft for knee OA
|
| Jan 14 |
Organogenesis Enrolls First Patient in Pivotal Phase 3 Clinical Trial of RMAT-Designated ReNu® for Knee Osteoarthritis
|
| Jan 13 |
Organogenesis +23% AH, expects revenue to rise 40-42% Y/Y
|
| Jan 13 |
Organogenesis Holdings Inc. Reports Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020
|
| Jan 11 |
Organogenesis' ReNu wins FDA's RMAT status
|
| Jan 11 |
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
|
| Jan 7 |
How Much Of Organogenesis Holdings Inc. (NASDAQ:ORGO) Do Insiders Own?
|
| Jan 5 |
Organogenesis Holdings Inc. to Participate in the ICR Conference 2021
|
| Jan 5 |
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
|
| Dec 30 |
The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data
|
| Dec 29 |
The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
|
| Dec 26 |
Organogenesis Holdings: Accumulate On Dips
|
| Dec 23 |
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
|
